A citation-based method for searching scientific literature

Simeon I Taylor, Jenny E Blau, Kristina I Rother, Amber L Beitelshees. Lancet Diabetes Endocrinol 2019
Times Cited: 18







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol.
Anette-Gabriele Ziegler, Peter Achenbach, Reinhard Berner, Kristina Casteels, Thomas Danne, Melanie Gündert, Joerg Hasford, Verena Sophia Hoffmann, Olga Kordonouri, Karin Lange,[...]. BMJ Open 2019
14
7

Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Jenny Aurielle B Babon, Megan E DeNicola, David M Blodgett, Inne Crèvecoeur, Thomas S Buttrick, René Maehr, Rita Bottino, Ali Naji, John Kaddis, Wassim Elyaman,[...]. Nat Med 2016
148
5

Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial.
William Hagopian, Robert J Ferry, Nicole Sherry, David Carlin, Ezio Bonvini, Syd Johnson, Kathryn E Stein, Scott Koenig, Anastasia G Daifotis, Kevan C Herold,[...]. Diabetes 2013
114
5

An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice.
Liliane Khoryati, Minh Nguyet Pham, McKenna Sherve, Swarnima Kumari, Kevin Cook, Josh Pearson, Marika Bogdani, Daniel J Campbell, Marc A Gavin. Sci Immunol 2020
6
16

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.
Araz Rawshani, Naveed Sattar, Stefan Franzén, Aidin Rawshani, Andrew T Hattersley, Ann-Marie Svensson, Björn Eliasson, Soffia Gudbjörnsdottir. Lancet 2018
172
5

Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
Jeffrey P Krischer, Desmond A Schatz, Brian Bundy, Jay S Skyler, Carla J Greenbaum. JAMA 2017
58
5

Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine.
Bart O Roep, Daniel C S Wheeler, Mark Peakman. Lancet Diabetes Endocrinol 2019
38
5


Current progress in stem cell therapy for type 1 diabetes mellitus.
Shuai Chen, Kechen Du, Chunlin Zou. Stem Cell Res Ther 2020
7
14

Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.
Rachel G Miller, Aaron M Secrest, Ravi K Sharma, Thomas J Songer, Trevor J Orchard. Diabetes 2012
140
5

Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Christopher C Patterson, Suvi Karuranga, Paraskevi Salpea, Pouya Saeedi, Gisela Dahlquist, Gyula Soltesz, Graham D Ogle. Diabetes Res Clin Pract 2019
53
5

Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
Somayeh Sabouri, Mehdi A Benkahla, William B Kiosses, Teresa Rodriguez-Calvo, Jose Zapardiel-Gonzalo, Ericka Castillo, Matthias G von Herrath. J Autoimmun 2020
4
25

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).
Bart O Roep, Sofia Thomaidou, René van Tienhoven, Arnaud Zaldumbide. Nat Rev Endocrinol 2021
10
10

β cell ER stress and the implications for immunogenicity in type 1 diabetes.
Meghan L Marré, Eddie A James, Jon D Piganelli. Front Cell Dev Biol 2015
56
5

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.
Stephen E Gitelman, Peter A Gottlieb, Mark R Rigby, Eric I Felner, Steven M Willi, Lynda K Fisher, Antoinette Moran, Michael Gottschalk, Wayne V Moore, Ashley Pinckney,[...]. Lancet Diabetes Endocrinol 2013
84
5

Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.
John R Petrie, Naveed Sattar. Circulation 2019
6
16

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Lancet 2011
346
5

Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis.
Amelia K Linnemann, Joshua C Neuman, Therese J Battiola, Jaclyn A Wisinski, Michelle E Kimple, Dawn Belt Davis. Mol Endocrinol 2015
34
5

The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
Ionut Bebu, Barbara H Braffett, Rodica Pop-Busui, Trevor J Orchard, David M Nathan, John M Lachin. Diabetologia 2017
34
5

Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial.
Bernt Johan von Scholten, Frederik Persson, Signe Rosenlund, Jesper Eugen-Olsen, Tomasz Pielak, Jens Faber, Tine W Hansen, Peter Rossing. Diabetes Obes Metab 2017
25
5

Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.
Helen M McGuire, Stacey Walters, Alexis Vogelzang, Carol M Y Lee, Kylie E Webster, Jonathan Sprent, Daniel Christ, Shane Grey, Cecile King. Diabetes 2011
61
5


T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.
Adam L Burrack, Tijana Martinov, Brian T Fife. Front Endocrinol (Lausanne) 2017
63
5

Genetic risk factors for type 1 diabetes.
Flemming Pociot, Åke Lernmark. Lancet 2016
197
5

Cardiovascular Risk in Type 1 Diabetes Mellitus.
Jonathan Schofield, Jan Ho, Handrean Soran. Diabetes Ther 2019
17
5

IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes.
Sakthi Rajendran, Florence Anquetil, Estefania Quesada-Masachs, Madeleine Graef, Nathaly Gonzalez, Sara McArdle, Tiffany Chu, Lars Krogvold, Knut Dahl-Jørgensen, Matthias von Herrath. Clin Immunol 2020
5
20

Autologous hematopoietic stem cell transplantation for type 1 diabetes.
Júlio C Voltarelli, Carlos E B Couri, Ana B P L Stracieri, Maria C Oliveira, Daniela A Moraes, Fabiano Pieroni, George M N Barros, Maria Isabel A Madeira, Kelen C R Malmegrim, Maria C Foss-Freitas,[...]. Ann N Y Acad Sci 2008
30
5

Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents.
Christine Ferrara-Cook, Susan Michelle Geyer, Carmella Evans-Molina, Ingrid M Libman, Dorothy J Becker, Stephen E Gitelman, Maria Jose Redondo. Diabetes Care 2020
7
14

B-lymphocyte depletion with rituximab and β-cell function: two-year results.
Mark D Pescovitz, Carla J Greenbaum, Brian Bundy, Dorothy J Becker, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Jennifer B Marks, Antoinette Moran, Philip Raskin,[...]. Diabetes Care 2014
113
5

Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.
François-Xavier Mauvais, Julien Diana, Peter van Endert. F1000Res 2016
7
14

Advances in technology for management of type 1 diabetes.
Roy W Beck, Richard M Bergenstal, Lori M Laffel, John C Pickup. Lancet 2019
38
5

How viral infections affect the autoimmune process leading to type 1 diabetes.
Christophe Filippi, Matthias von Herrath. Cell Immunol 2005
52
5

Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
Gina J Ryan, Lynetta J Jobe, Rhonda Martin. Clin Ther 2005
71
5


Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
Jing Lu Kroll, Craig Beam, Shaobing Li, Raphael Viscidi, Bonnie Dighero, Alice Cho, David Boulware, Mark Pescovitz, Adriana Weinberg. J Clin Virol 2013
21
5

Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.
Bart Keymeulen, Sophie Candon, Samira Fafi-Kremer, Anette Ziegler, Marianne Leruez-Ville, Chantal Mathieu, Evy Vandemeulebroucke, Markus Walter, Laurent Crenier, Eric Thervet,[...]. Blood 2010
55
5


Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries.
Ruth S Weinstock, Ingrid Schütz-Fuhrmann, Crystal G Connor, Julia M Hermann, David M Maahs, Morten Schütt, Shivani Agarwal, Sabine E Hofer, Roy W Beck, Reinhard W Holl. Diabetes Res Clin Pract 2016
25
5

Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2.
Connor J Dwyer, Natasha C Ward, Alberto Pugliese, Thomas R Malek. Curr Diab Rep 2016
28
5

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Björn Eliasson, Ann-Marie Svensson, Mervete Miftaraj, Darren K McGuire, Naveed Sattar, Annika Rosengren, Soffia Gudbjörnsdottir. N Engl J Med 2017
414
5

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Johannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, Steven P Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B Buse. N Engl J Med 2017
423
5


Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.
Chang-yun Hu, Daniel Rodriguez-Pinto, Wei Du, Anupama Ahuja, Octavian Henegariu, F Susan Wong, Mark J Shlomchik, Li Wen. J Clin Invest 2007
292
5

Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus.
Andrew E Hogan, Gadintshware Gaoatswe, Lydia Lynch, Michelle A Corrigan, Conor Woods, Jean O'Connell, Donal O'Shea. Diabetologia 2014
79
5

Interleukin-21 is required for the development of type 1 diabetes in NOD mice.
Andrew P R Sutherland, Tom Van Belle, Andrea L Wurster, Akira Suto, Monia Michaud, Dorothy Zhang, Michael J Grusby, Matthias von Herrath. Diabetes 2009
117
5

Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
Eddie A James, Massimo Pietropaolo, Mark J Mamula. Diabetes 2018
36
5

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.
Manuela Battaglia, Simi Ahmed, Mark S Anderson, Mark A Atkinson, Dorothy Becker, Polly J Bingley, Emanuele Bosi, Todd M Brusko, Linda A DiMeglio, Carmella Evans-Molina,[...]. Diabetes Care 2020
52
5

Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.
Emma L Smith, Mark Peakman. Front Immunol 2018
22
5

Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
Johnny Ludvigsson, Jeanette Wahlberg, Rosaura Casas. N Engl J Med 2017
20
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.